Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0046 | 0.0482 | 0.1437 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0261 | 0.8803 | 0.5 |
Brugia malayi | mbt repeat family protein | 0.0048 | 0.0558 | 0.1664 |
Echinococcus granulosus | SAM and MBT domain containing protein | 0.0048 | 0.0558 | 0.0092 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.019 | 0.6025 | 0.6661 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0048 | 0.0558 | 0.008 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0046 | 0.0482 | 0.1437 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0815 | 0.2432 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF7 | 0.0261 | 0.8803 | 0.5 |
Brugia malayi | mbt repeat family protein | 0.0048 | 0.0558 | 0.1664 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0048 | 0.0558 | 0.008 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.012 | 0.3352 | 1 |
Loa Loa (eye worm) | mbt repeat family protein | 0.0048 | 0.0558 | 0.1664 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.0261 | 0.8803 | 0.5 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0055 | 0.0815 | 0.2432 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0055 | 0.0815 | 0.0401 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.0261 | 0.8803 | 0.5 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0055 | 0.0815 | 0.0401 |
Onchocerca volvulus | Polycomb protein Sfmbt homolog | 0.0048 | 0.0558 | 0.5 |
Echinococcus multilocularis | ATP dependent DNA helicase PIF1 | 0.0261 | 0.8803 | 1 |
Echinococcus multilocularis | SAM and MBT domain containing protein | 0.0048 | 0.0558 | 0.0092 |
Echinococcus granulosus | ATP dependent DNA helicase PIF1 | 0.0261 | 0.8803 | 1 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.019 | 0.6025 | 0.6661 |
Onchocerca volvulus | 0.0048 | 0.0558 | 0.5 | |
Brugia malayi | MH2 domain containing protein | 0.012 | 0.3352 | 1 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0055 | 0.0815 | 0.035 |
Schistosoma mansoni | scm-relatedprotein containing 4 mbt domains (sfmbt) | 0.0048 | 0.0558 | 0.008 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0055 | 0.0815 | 0.0401 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.012 | 0.3352 | 1 |
Giardia lamblia | Rrm3p helicase | 0.0261 | 0.8803 | 0.5 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.0261 | 0.8803 | 0.5 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.0261 | 0.8803 | 0.5 |
Echinococcus granulosus | polycomb protein SCMH1 | 0.0048 | 0.0558 | 0.0092 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0558 | 0.1664 |
Schistosoma mansoni | hypothetical protein | 0.0261 | 0.8803 | 0.8743 |
Loa Loa (eye worm) | MBCTL1 | 0.0055 | 0.0815 | 0.2432 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0261 | 0.8803 | 0.5 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0055 | 0.0815 | 0.0401 |
Entamoeba histolytica | DNA repair and recombination protein, putative | 0.0261 | 0.8803 | 0.5 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF6, putative | 0.0261 | 0.8803 | 0.5 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF6 | 0.0261 | 0.8803 | 0.5 |
Echinococcus multilocularis | polycomb protein SCMH1 | 0.0048 | 0.0558 | 0.0092 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MPC (binding) | = 3.1 ug ml-1 | Minimum protective concentration used to protect the compound against K. pneumoniae A20634 beta-lactamase catalyzed hydrolysis | ChEMBL. | 3872369 |
MPC (binding) | = 3.1 ug ml-1 | Minimum protective concentration used to protect the compound against S. aureus A9606 beta-lactamase catalyzed hydrolysis | ChEMBL. | 3872369 |
MPC (binding) | = 12.5 ug ml-1 | Minimum protective concentration used to protect the compound against B. fragilis A-22,695 beta-lactamase catalyzed hydrolysis | ChEMBL. | 3872369 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.